These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3529516)

  • 21. [A comparison of measurements of serum free thyroxine concentration by equilibrium dialysis and ultrafiltration using undiluted serum].
    Konno N; Hagiwara K; Nakata M; Taguchi H
    Kaku Igaku; 1991 Jul; 28(7):719-28. PubMed ID: 1920948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propranolol binding in serum: comparison of methods and investigation of effects of drug concentration, pH, and temperature.
    Paxton JW; Calder RL
    J Pharmacol Methods; 1983 Aug; 10(1):1-11. PubMed ID: 6632919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function.
    Drayer DE; Lowenthal DT; Restivo KM; Schwartz A; Cook CE; Reidenberg MM
    Clin Pharmacol Ther; 1978 Jul; 24(1):31-9. PubMed ID: 657716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting quinidine protein binding in humans.
    Edwards DJ; Axelson JE; Slaughter RL; Elvin AT; Lalka D
    J Pharm Sci; 1984 Sep; 73(9):1264-7. PubMed ID: 6491948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzyme immunoassay and two fluorometric methods compared for the determination of quinidine in serum.
    Pape BE
    Ther Drug Monit; 1981; 3(4):357-63. PubMed ID: 7039008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caucasian versus African-American differences in orosomucoid: potential implications for therapy.
    McCollam PL; Crouch MA; Arnaud P
    Pharmacotherapy; 1998; 18(3):620-6. PubMed ID: 9620113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of sustained-release quinidines given twice daily to patients with ventricular ectopy.
    Lehmann CR; Boran KJ; Kruyer WB; Van Reet RE; Scoville GS; Pierson WP; Melikian AP; Crowe JT; Wright GJ
    J Clin Pharmacol; 1986; 26(8):598-604. PubMed ID: 3793950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-performance liquid chromatographic method for the quantitation of quinidine and selected quinidine metabolites.
    Hoyer GL; Clawson DC; Brookshier LA; Nolan PE; Marcus FI
    J Chromatogr; 1991 Dec; 572(1-2):159-69. PubMed ID: 1818051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simple and selective high-performance liquid chromatographic method for estimating plasma quinidine levels.
    Reece PA; Peikert M
    J Chromatogr; 1980 Feb; 181(2):207-17. PubMed ID: 7372754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quinidine determination in serum: enzyme immunoassay (EIA) V HPLC.
    Ha HR; Kewitz G; Wenk M; Follath F
    Br J Clin Pharmacol; 1981 Mar; 11(3):312-4. PubMed ID: 7011351
    [No Abstract]   [Full Text] [Related]  

  • 31. Protein binding of ceftriaxone: comparison of three techniques of determination and the effect of 2-hydroxybenzoylglycine, a drug-binding inhibitor in uremia.
    Fiset C; Vallée F; LeBel M; Bergeron MG
    Ther Drug Monit; 1986; 8(4):483-9. PubMed ID: 3824437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved liquid-chromatographic assay of quinidine and its metabolites in biological fluids.
    Rakhit A; Kunitani M; Holford NH; Riegelman S
    Clin Chem; 1982 Jul; 28(7):1505-9. PubMed ID: 7083565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The "ultra-free" ultrafiltration technique compared with equilibrium dialysis for determination of unbound thiopental concentrations in serum.
    Jung D; Mayersohn M; Perrier D
    Clin Chem; 1981 Jan; 27(1):166-8. PubMed ID: 7449102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of high (3S)-3-hydroxyquinidine/quinidine ratios in serum, and clearance of quinidine in cardiac patients with age.
    Drayer DE; Hughes M; Lorenzo B; Reidenberg MM
    Clin Pharmacol Ther; 1980 Jan; 27(1):72-5. PubMed ID: 7351119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct measurement of serum free testosterone by ultrafiltration followed by liquid chromatography tandem mass spectrometry.
    Chen Y; Yazdanpanah M; Wang XY; Hoffman BR; Diamandis EP; Wong PY
    Clin Biochem; 2010 Mar; 43(4-5):490-6. PubMed ID: 20026023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in the binding of quinine and quinidine to plasma proteins.
    Mihaly GW; Ching MS; Klejn MB; Paull J; Smallwood RA
    Br J Clin Pharmacol; 1987 Dec; 24(6):769-74. PubMed ID: 3440096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma protein-binding and CSF concentrations of valproic acid in man following acute oral dosing.
    Rapeport WG; Mendelow AD; French G; MacPherson P; Teasdale E; Agnew E; Thompson GG; Brodie MJ
    Br J Clin Pharmacol; 1983 Oct; 16(4):365-9. PubMed ID: 6414500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered protein binding of quinidine in patients with atrial fibrillation and flutter.
    McCollam PL; Crouch MA; Watson JE
    Pharmacotherapy; 1997; 17(4):753-9. PubMed ID: 9250553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma concentrations of quinidine, its major metabolites, and dihydroquinidine in patients with torsades de pointes.
    Thompson KA; Murray JJ; Blair IA; Woosley RL; Roden DM
    Clin Pharmacol Ther; 1988 Jun; 43(6):636-42. PubMed ID: 3378385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of quinidine by fluorescence polarization immunoassay and high pressure liquid chromatography.
    Bridges RR; Smith CM; Jennison TA
    J Anal Toxicol; 1984; 8(4):161-3. PubMed ID: 6381883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.